A first-in-human phase I study of U3-1287 (AMG 888), a HER3 inhibitor, in patients (pts) with advanced solid tumors Meeting Abstract
| Authors: | Berlin, J.; Keedy, V. L.; Janne, P. A.; Yee, L.; Rizvi, N. A.; Jin, X.; Copigneaux, C.; Hettmann, T.; Beaupre, D. M.; LoRusso, P. |
| Abstract Title: | A first-in-human phase I study of U3-1287 (AMG 888), a HER3 inhibitor, in patients (pts) with advanced solid tumors |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880301455 |
| DOI: | 10.1200/jco.2011.29.15_suppl.3026 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3026 -- Source: Wos |
